Meningococcal Vaccine 76% Effective for Kids Under 5, Study Says

(MedPage Today) -- Complete vaccination with the four-component, protein-based meningococcal serogroup B vaccine (4CMenB; Bexsero) was found to be effective in the prevention of invasive serogroup B and non-serogroup B disease among children younger...
Source: MedPage Today Public Health - Category: American Health Source Type: news